Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Short Candidates -- Ignore unavailable to you. Want to Upgrade?

To: keokalani'nui who wrote (210)	4/5/2002 1:30:06 PM
From: tuck	Read Replies (1) \| Respond to of 897

Not sure how to handle this portfolio in terms of reporting profits taken. Create a profits field and put 'em in there, I guess. Suggestions? Almost shorted DNDN when it popped over $6 for no apparent reason; wish I had. Another shoulda, coulda, woulda: Miljenko's call on CVTX ~$55. He targeted the $30s, and it's there. Nice going, Miljenko, got any more? And good timing yourself, Wilder, on GNTA. That would have been a good short term trade. Wish you had convinced me somehow. This seems to be an environment where hesitating and doing DD causes one to miss opportunities. Over on the BVF thread, there has been talk of certain funds in trouble liquidating, and other funds shorting in front of them. Maybe that's why Patrick Adams, a fund manager, was recently quoted as saying there was more money to be made shorting biotechs than going long. Anyhow, with the above in mind, I'm going to try that concept into the mid month. On the theory that there may be liquidations going on for folks that need to pay their taxes, on top of other unfriendly dynamics. Even if I lose some on this, DIO seems to have assured my record for a while. More than I can say for my long portfolios. Thoughts? Candidates? Cheers, Tuck